Daily Brief Thematic (Sector/Industry): Japan Weekly | A Bull Market? Shiseido and more

In today’s briefing:

Japan Weekly | A Bull Market? Shiseido, TEL, Lasertec
China Healthcare Weekly (Nov.11)-Largest Spring Coil VBP; Biological Drug VBP; FDA Changes Game Rule
GEM Weekly (11 Nov 2022): Chinese Inflation, Malaysia, Indonesia GDP; Reliance, Jio, TSMC

Japan Weekly | A Bull Market? Shiseido, TEL, Lasertec

It has been a positive week for Japanese equities, especially the tech, consumer and industrial names that we keep a watchful eye on.
One hundred out of the 120 stocks that we have on our watchlist recorded positive gains, with a median return of 3.5%
Are we in a bull market? 90 of the names are trading above the 50d Moving Average. Lasertec is looking the most stretched: 47% above the 50d

The “Spring Coil Alliance Centralized Procurement” in 21 provinces led by Jilin is about to start. Such large-scale centralized procurement has certain reference significance for future nationwide centralized procurement expansion.
The rules and varieties of 8th national VBP could change, and biological drugs may be included in VBP together with chemical drugs.
The US FDA has recently tightened the policy of accelerated approval, which is correct, because at present, pharmaceutical enterprises are trying to “exploit loopholes”.

The Global Emerging Markets weekly provides a summary of the key news and related developments impacting the largest countries and constituents of the Global Emerging Markets equity indices.
Macro data points: Chinese inflation data; Malaysian and Indonesian GDP growth
Companies mentioned:Taiwan Semiconductor (TSMC) (2330 TT), Reliance Communications (RCOM IN), Jio

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network